Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.07 EUR | +0.07% |
|
-0.15% | -22.44% |
11:34am | Bayer: new positive data for Nubeqa | CF |
10:44am | Bayer with trial success in prostate cancer - Analyst: As expected | DP |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.44% | 27.86B | |
+61.53% | 848B | |
+33.69% | 627B | |
-3.66% | 363B | |
+15.06% | 318B | |
+9.18% | 299B | |
+11.98% | 234B | |
+16.13% | 225B | |
+15.67% | 179B | |
+2.47% | 167B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Bayer's Prostate Cancer Combo Extends Progression-Free Survival in Late-stage Trial